• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗真菌药物耐药性的分子机制综述:更新与最新进展。

A Review on Molecular Mechanisms of Antifungal Resistance in : Update and Recent Advances.

机构信息

Department of Medical Parasitology and Mycology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Microb Drug Resist. 2021 Oct;27(10):1371-1388. doi: 10.1089/mdr.2020.0235. Epub 2021 May 5.

DOI:10.1089/mdr.2020.0235
PMID:33956513
Abstract

is the second frequent etiologic agent of mucosal and invasive candidiasis. Based on the recent developments in molecular methods, has been introduced as a complex composed of , , and . The four main classes of antifungal drugs effective against are pyrimidine analogs (flucytosine), azoles, echinocandins, and polyenes. Although the use of antifungal drugs is related to the predictable development of drug resistance, it is not clear why is able to rapidly resist against multiple antifungals in clinics. The enhanced incidence and antifungal resistance of and the high mortality and morbidity need more investigation regarding the resistance mechanisms and virulence associated with ; additional progress concerning the drug resistance of has to be further prevented. The present review highlights the mechanism of resistance to antifungal drugs in .

摘要

是黏膜和侵袭性念珠菌病的第二大常见病因。基于分子方法的最新进展,已被介绍为一种由、、和组成的复合体。有 4 类主要的抗真菌药物对有效,即嘧啶类似物(氟胞嘧啶)、唑类、棘白菌素类和多烯类。尽管抗真菌药物的使用与可预测的耐药性发展有关,但尚不清楚为什么在临床上能够迅速对多种抗真菌药物产生耐药性。和的发生率增加和抗真菌药物耐药性以及高死亡率和发病率需要更多地研究与耐药性相关的机制和与毒力相关的因素;需要进一步防止进一步的耐药性进展。本综述强调了抗真菌药物耐药性的机制。

相似文献

1
A Review on Molecular Mechanisms of Antifungal Resistance in : Update and Recent Advances.抗真菌药物耐药性的分子机制综述:更新与最新进展。
Microb Drug Resist. 2021 Oct;27(10):1371-1388. doi: 10.1089/mdr.2020.0235. Epub 2021 May 5.
2
Phenotypic and Molecular Evaluation of Echinocandin Susceptibility of Candida glabrata, Candida bracarensis, and Candida nivariensis Strains Isolated during 30 Years in Argentina.阿根廷30年间分离出的光滑念珠菌、布拉氏念珠菌和 nivariensis 念珠菌菌株棘白菌素敏感性的表型和分子评估
Antimicrob Agents Chemother. 2017 Jun 27;61(7). doi: 10.1128/AAC.00170-17. Print 2017 Jul.
3
Identification of genetic markers of resistance to echinocandins, azoles and 5-fluorocytosine in Candida glabrata by next-generation sequencing: a feasibility study.通过下一代测序技术鉴定光滑念珠菌对棘白菌素类、唑类和 5-氟胞嘧啶耐药的遗传标记:一项可行性研究。
Clin Microbiol Infect. 2017 Sep;23(9):676.e7-676.e10. doi: 10.1016/j.cmi.2017.03.014. Epub 2017 Mar 23.
4
Tipping the balance both ways: drug resistance and virulence in Candida glabrata.双向权衡:光滑念珠菌的耐药性与毒力
FEMS Yeast Res. 2015 Jun;15(4):fov025. doi: 10.1093/femsyr/fov025. Epub 2015 May 15.
5
Absence of Azole or Echinocandin Resistance in Candida glabrata Isolates in India despite Background Prevalence of Strains with Defects in the DNA Mismatch Repair Pathway.尽管印度存在背景流行的 DNA 错配修复途径缺陷菌株,但光滑念珠菌分离株中不存在唑类或棘白菌素耐药性。
Antimicrob Agents Chemother. 2018 May 25;62(6). doi: 10.1128/AAC.00195-18. Print 2018 Jun.
6
The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.棘白菌素类、两性霉素 B 和伏立康唑对氟康唑敏感和氟康唑耐药巴西光滑念珠菌分离株的活性。
Mem Inst Oswaldo Cruz. 2012 May;107(3):433-6. doi: 10.1590/s0074-02762012000300022.
7
Prevalence and Antifungal Susceptibility of the Emerging Fungal Species, , Isolated in a Teaching Hospital in Poland.在波兰的一家教学医院中分离出的新兴真菌种 的流行情况和抗真菌药敏性。
Pol J Microbiol. 2019 Sep;68(3):303-308. doi: 10.33073/pjm-2019-032. Epub 2019 Sep 3.
8
Assessment of the in vitro kinetic activity of caspofungin against Candida glabrata.评估卡泊芬净对光滑念珠菌的体外动力学活性。
Antimicrob Agents Chemother. 2010 Jan;54(1):522-5. doi: 10.1128/AAC.01339-08. Epub 2009 Oct 19.
9
Commonly Used Oncology Drugs Decrease Antifungal Effectiveness against Candida and Aspergillus Species.常用肿瘤药物降低抗真菌药物对念珠菌属和曲霉菌属的疗效。
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00504-18. Print 2018 Jul.
10
Activity of Combined Antifungal Agents Against Multidrug-Resistant Candida glabrata Strains.联合抗真菌药物对耐多药光滑念珠菌的活性。
Mycopathologia. 2017 Oct;182(9-10):819-828. doi: 10.1007/s11046-017-0141-9. Epub 2017 May 10.

引用本文的文献

1
Antifungal Drugs for the Treatment of Invasive Fungal Infections-A Limited Therapeutic Toolbox Facing Growing Resistances.用于治疗侵袭性真菌感染的抗真菌药物——面对不断增加的耐药性,一个有限的治疗手段库
Pharmaceuticals (Basel). 2025 Aug 19;18(8):1220. doi: 10.3390/ph18081220.
2
and : global priority pathogens.和:全球优先病原体。
Microbiol Mol Biol Rev. 2024 Jun 27;88(2):e0002123. doi: 10.1128/mmbr.00021-23. Epub 2024 Jun 4.
3
A Rare Case of Cervical Spondylodiscitis.一例罕见的颈椎椎间盘炎病例。
HCA Healthc J Med. 2023 Dec 30;4(6):425-428. doi: 10.36518/2689-0216.1577. eCollection 2023.
4
The regulatory subunits of CK2 complex mediate DNA damage response and virulence in Candida Glabrata.CK2 复合物的调节亚基介导假丝酵母菌属光滑念珠菌的 DNA 损伤反应和毒力。
BMC Microbiol. 2023 Oct 28;23(1):317. doi: 10.1186/s12866-023-03069-4.
5
Fungal Drug Response and Antimicrobial Resistance.真菌药物反应与抗菌耐药性
J Fungi (Basel). 2023 May 12;9(5):565. doi: 10.3390/jof9050565.
6
Liposomal amphotericin B-the future.脂质体两性霉素 B——未来。
J Antimicrob Chemother. 2022 Nov 25;77(Suppl_2):ii21-ii34. doi: 10.1093/jac/dkac353.
7
Meyerozyma guilliermondii species complex: review of current epidemiology, antifungal resistance, and mechanisms.梅伊罗泽姆酵母种复合体:当前流行病学、抗真菌耐药性和机制的综述。
Braz J Microbiol. 2022 Dec;53(4):1761-1779. doi: 10.1007/s42770-022-00813-2. Epub 2022 Oct 28.
8
Overview on the Infections Related to Rare Species.稀有物种相关感染概述
Pathogens. 2022 Aug 24;11(9):963. doi: 10.3390/pathogens11090963.